Jeffrey S. Rose, Derek S. Serna, Ludmila Katherine Martin, Xiaobai Li, Lynn M. Weatherby, Sherif Abdel-Misih, Weiqiang Zhao and Tanios Bekaii-Saab Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma Cancer 118
Version of Record online: 6 JUN 2012 | DOI: 10.1002/cncr.27666
The prognostic value of v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) status in colorectal cancer remains poorly understood. In this study, KRAS mutation status does not influence overall survival in either synchronous or metachronous metastatic colorectal adenocarcinoma and, as such, has no prognostic role in this disease setting.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field